key: cord-0884621-9ch4wevl
authors: Vanegas Ramirez, A.; Efe, D.; Fischer, M.
title: Drug‐induced vasculitis in a patient with COVID‐19
date: 2020-05-27
journal: J Eur Acad Dermatol Venereol
DOI: 10.1111/jdv.16588
sha: b48022712fe67a22be959e9c59cd6c0686e3182a
doc_id: 884621
cord_uid: 9ch4wevl

A 57-year-old German woman with a history of skin reactions to unknown antibiotics, depression and high blood pressure presented with a 2-day history of symmetrically distributed pruritic pink-to-red maculopapular exanthema on the trunk and extremities. Due to a 3-week history of a nonproductive cough and intermittent fever she has taken amoxicillin, ibuprofen and metamizole three days before. She did not take aspirin or other anticoagulants. This prescription was discontinued and an intravenous bolus of prednisolone as well as anthistamines and topical glucocorticoids were administered.

(RT-PCR) assay of a throat swab was positive. A biopsy specimen of the skin lesion revealed a vasculitis. Blood tests for HIV, antinuclear antibodies and antineutrophyle cytoplasmic antibodies were negative.

The patient was treated with 120 mg of prednisolone per day (1.5 mg per kilogram of body weight). After 9 days, the patient's skin lesions and her respiratory symptoms improved. Two negative SARS-CoV-2 by RT-PCR tests of throat swabs with sampling interval of 24 h were confirmed and the patient was discharged home.

Despite an antibiotic allergy could developed the rash and vasculitis in our patient, it is known that severe COVID-19 induces endothelial damage and thrombosis. 1,2 Some reports have showed urticaria, rash, vesicles, purpura, chilblain-like and erythema multiforme-like patterns as cutaneous manifestations in patients with COVID-19. [2] [3] [4] [5] [6] This case report illustrates the potential of COVID-19 infections to trigger severe drug-related skin reactions such as vasculitis. More evidence is needed to understand the association of COVID-19 and cutaneous manifestations.

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The perspectives of clinical immunologists from China

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Cutaneous manifestations in COVID-19: a first perspective

Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak

Vascular skin symptoms in COVID-19: a french observational study

Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome

We would like to thank the patient cited in this manuscript that has given a written informed consent to the publication of her case details and photographs.